2013 BioPharmAsia ”Asia’s 20 Most Promising Biotech Companies”


2013 Phase II/III Clinical Trial Approval for Icaritin


2011 Key Technical Research Project of Haidian District, Beijing


2011 Beijing High-Tech Enterprises


2011 Top 10 Zhongguancun VC Cases


2010 Beijing Intellectual Property Pilot Enterprises


2009 Member Enterprises of Beijing Zhongguancun High-Tech Enterprises Association


2009 Member of China Medicinal Biotech Association


2008 ChinaBio VC Congress “Chinese Most Promising Biotech Company”


2008 Member Enterprises of China Chinese Medicine Institute


2008 Board Member of Pharmaceutical Biotechnology Union


2008 Three World-class Scientists of Breast Cancer Research Joined Shenogen Scientific Advisory Board


    Awards & Recognitions